Literature DB >> 8264652

Loss of thrombospondin transcriptional activity in nickel-transformed cells.

K Salnikow1, S Cosentino, C Klein, M Costa.   

Abstract

mRNA from normal Chinese hamster embryo (CHE) cells was transcribed to cDNA and subtracted with an excess of mRNA from Chinese hamster embryo cells transformed by nickel compounds. Here we report the recovery of a sequence found to be highly homologous to the mouse thrombospondin 1 gene that was obtained by this subtraction procedure. Since thrombospondin is antiangiogenic, cancer cells expressing high levels of thrombospondin cannot grow in vivo because capillaries will not proliferate to cells secreting thrombospondin. To examine expression of thrombospondin, normal CHE cells were stained with monoclonal antibodies to human thrombospondin. The protein was present abundantly in the cytoplasm of normal cells but at greatly reduced levels in Ni-transformed cells. Analysis of mRNA by Northern (RNA) blot revealed transcripts in normal cells but little thrombospondin mRNA in Ni-transformed cells. Loss of thrombospondin mRNA expression was related to Ni treatment rather than transformation, since Ni-resistant cells also exhibited fewer thrombospondin transcripts than did wild-type cells. Digestion of genomic DNA with various combinations of restriction enzymes revealed thrombospondin gene patterns that were identical in both cell types, suggesting that there were no major deletions or rearrangements of the gene in the nickel-transformed cells. The inactivation of the thrombospondin gene was further investigated by analyzing the promoter activity of this gene linked to a chloramphenicol acetyltransferase (CAT) reporter plasmid that was transfected into normal and Ni-transformed cells. The CAT activity in normal cells was significantly higher than in Ni-transformed cells, suggesting that the promoter region of thrombospondin was less efficiently transcribed in Ni-transformed cells. We studied the consequences of enhanced expression of the retinoblastoma (Rb) gene, a known tumor suppressor gene, on CAT transcription driven by the human thrombospondin promoter. Cotransfection of an expression vector containing the mouse Rb gene greatly enhanced the transcription from the thrombospondin promoter such that the expression was higher in normal cells than in transformed cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264652      PMCID: PMC358433          DOI: 10.1128/mcb.14.1.851-858.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor.

Authors:  R A Majack; J Mildbrandt; V M Dixit
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

3.  Regulation of thrombospondin secretion by cells in culture.

Authors:  S M Mumby; D Abbott-Brown; G J Raugi; P Bornstein
Journal:  J Cell Physiol       Date:  1984-09       Impact factor: 6.384

4.  Effect of magnesium on nickel-induced genotoxicity and cell transformation.

Authors:  K Conway; X W Wang; L S Xu; M Costa
Journal:  Carcinogenesis       Date:  1987-08       Impact factor: 4.944

5.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium.

Authors:  H Sage; P Pritzl; P Bornstein
Journal:  Arteriosclerosis       Date:  1981 Nov-Dec

7.  Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin.

Authors:  J McPherson; H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

8.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation.

Authors:  A Stoler; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Solubilization of the carcinogen nickel subsulfide and its interaction with deoxyribonucleic acid and protein.

Authors:  J E Lee; R B Ciccarelli; K W Jennette
Journal:  Biochemistry       Date:  1982-02-16       Impact factor: 3.162

10.  Binding and degradation of platelet thrombospondin by cultured fibroblasts.

Authors:  P J McKeown-Longo; R Hanning; D F Mosher
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

View more
  14 in total

1.  Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.

Authors:  J Cinatl; R Kotchetkov; M Scholz; J Cinatl; J U Vogel; P H Driever; H W Doerr
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  Peroxidase deficiency of nickel-transformed hamster cells correlates with their increased resistance to cytotoxicity of peroxides.

Authors:  W K Dowjat; X Huang; S Cosentino; M Costa
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

Review 3.  Carcinogenic effect of nickel compounds.

Authors:  Haitian Lu; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

4.  Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression.

Authors:  Weiming Ouyang; Jingxia Li; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

5.  Inhibition of core histones acetylation by carcinogenic nickel(II).

Authors:  Filip Golebiowski; Kazimierz S Kasprzak
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

6.  In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.

Authors:  S Filleur; O V Volpert; A Degeorges; C Voland; F Reiher; P Clézardin; N Bouck; F Cabon
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

Review 7.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

8.  Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens.

Authors:  Y W Lee; C B Klein; B Kargacin; K Salnikow; J Kitahara; K Dowjat; A Zhitkovich; N T Christie; M Costa
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 9.  Ascorbate depletion: a critical step in nickel carcinogenesis?

Authors:  Konstantin Salnikow; Kazimierz S Kasprzak
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

10.  SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

Authors:  A Mettouchi; F Cabon; N Montreau; P Vernier; G Mercier; D Blangy; H Tricoire; P Vigier; B Binétruy
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.